← Back to Search

Pediatric and adults suspected of acute bacterial or viral infection for Acute Infection

N/A
Waitlist Available
Research Sponsored by MeMed Diagnostics Ltd.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 18 months
Awards & highlights

Summary

This is a Prospective, multi-center, sample collection study enrolling pediatric and adult subjects presented to the ED/Urgent care, with symptoms consistent with acute bacterial or viral infection will be recruited according to eligibility criteria. The study is designed to measure the MeMed BV®️ score in whole blood and serum samples and demonstrate the equivalence between the two matrices. Patients will be managed according to the current standard of care per standard institutional procedures.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 18 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 18 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Measuring the MeMed BV® score with whole blood and serum samples from patients suspected of acute bacterial or viral infection and demonstrating the equivalence between the two matrices.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Pediatric and adults suspected of acute bacterial or viral infectionExperimental Treatment1 Intervention
ED, Hospital admitted, and urgent care center patients over the age of 90 days, with clinical suspicion of acute bacterial or viral infection.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MeMed BV®
2022
N/A
~520

Find a Location

Who is running the clinical trial?

MeMed Diagnostics Ltd.Lead Sponsor
15 Previous Clinical Trials
12,457 Total Patients Enrolled
1 Trials studying Acute Infection
1,384 Patients Enrolled for Acute Infection
~60 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top